Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The biopharmaceutical sector today is characterized by its intricacy, driven by increasing demands for enhanced specificity and safety, the emergence of new treatment classes, and the complexity of disease mechanisms. To navigate this intricate landscape, a profound comprehension of therapeutic dynamics is essential. Advanced modeling and simulation techniques offer a distinctive approach to investigate biological and physicochemical phenomena at the atomic scale. This methodology not only informs physical experimentation but also expedites the drug discovery and development phases. BIOVIA Discovery Studio integrates more than three decades of peer-reviewed research with cutting-edge in silico methodologies, including molecular mechanics, free energy assessments, and biotherapeutics developability, all within a unified framework. By equipping researchers with a comprehensive suite of tools, it facilitates a deeper examination of protein chemistry, thereby accelerating the discovery of both small and large molecule therapeutics, from Target Identification all the way through to Lead Optimization. Ultimately, this synergy of research and technology underscores the vital role of innovative tools in transforming biopharmaceutical advancements.
Description
Without a dedicated risk management toolset, you are likely wasting valuable time and resources, while also diminishing the effectiveness of any manager. To evaluate your current situation, use the Value of Integration checklist to determine whether a toolset is necessary for your operations. Once you recognize the importance of having such a toolset, the next step is to identify which one will best suit your needs. This brochure presents an overview of RiskOrganizer, allowing you to contrast it with alternative options available on the market. Effective risk management begins with an individual tasked with achieving a specific goal, who is also charged with overseeing the risks that may impede that goal. This responsibility could fall to a Project Manager or a member of the team, and they must ensure the accuracy and integrity of the data they manage. The ongoing management interface is tailored for risk managers, with a focus on treatment options. Treatment filters are designed to include the owners of specific treatments, facilitating targeted communication and discussions among the relevant team members as necessary. By implementing a suitable toolset, you can enhance collaboration and streamline risk management processes significantly.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
$49 per user per month
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Dassault Systèmes
Founded
1981
Country
France
Website
www.3ds.com/products-services/biovia/products/molecular-modeling-simulation/biovia-discovery-studio/
Vendor Details
Company Name
RiskTools
Country
Australia
Website
www.risktools.com.au
Product Features
Product Features
Risk Management
Alerts/Notifications
No
Auditing
No
Business Process Control
Yes
Compliance Management
No
Corrective Actions (CAPA)
No
Dashboard
No
Exceptions Management
No
IT Risk Management
No
Internal Controls Management
Yes
Legal Risk Management
No
Mobile Access
No
Operational Risk Management
No
Predictive Analytics
No
Reputation Risk Management
No
Response Management
No
Risk Assessment
Yes